Overexpression of the Axl tyrosine kinase receptor in cutaneous SCC-derived cell lines and tumours
dc.contributor.author | Green, J | en_US |
dc.contributor.author | Ikram, M | en_US |
dc.contributor.author | Vyas, J | en_US |
dc.contributor.author | Patel, N | en_US |
dc.contributor.author | Proby, CM | en_US |
dc.contributor.author | Ghali, L | en_US |
dc.contributor.author | Leigh, IM | en_US |
dc.contributor.author | O'Toole, EA | en_US |
dc.contributor.author | Storey, A | en_US |
dc.date.accessioned | 2016-11-29T12:20:29Z | |
dc.date.issued | 2006-05-22 | en_US |
dc.date.submitted | 2015-12-14T16:33:06.496Z | |
dc.identifier.issn | 0007-0920 | en_US |
dc.identifier.other | 10.1038/sj.bjc.6603135 | |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/17992 | |
dc.description.sponsorship | This research was supported by funding from Cancer Research UK and AICR Grant 03-315 to EA O’Toole. | en_US |
dc.format.extent | 1446 - 1451 | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | BRIT J CANCER | en_US |
dc.rights | Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. | |
dc.subject | Axl | en_US |
dc.subject | skin cancer | en_US |
dc.subject | receptor tyrosine kinase | en_US |
dc.subject | GEFITINIB IRESSA | en_US |
dc.subject | SKIN-CANCER | en_US |
dc.subject | EXPRESSION | en_US |
dc.subject | CARCINOMA | en_US |
dc.subject | ZD1839 | en_US |
dc.subject | GENE | en_US |
dc.subject | IMATINIB | en_US |
dc.subject | INHIBITORS | en_US |
dc.subject | ANTIBODY | en_US |
dc.subject | THERAPY | en_US |
dc.title | Overexpression of the Axl tyrosine kinase receptor in cutaneous SCC-derived cell lines and tumours | en_US |
dc.type | Article | |
dc.rights.holder | 2006 Cancer Research UK | |
dc.identifier.doi | 10.1038/sj.bjc.6603135 | en_US |
pubs.issue | 10 | en_US |
pubs.notes | Not known | en_US |
pubs.volume | 94 | en_US |